Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(2.06)
# 2,989
Out of 5,072 analysts
54
Total ratings
36.73%
Success rate
-2.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGTX MeiraGTx Holdings | Initiates: Buy | $20 | $8.20 | +143.90% | 1 | Nov 24, 2025 | |
| LYEL Lyell Immunopharma | Maintains: Neutral | $10 → $20 | $24.41 | -18.07% | 1 | Nov 24, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $30 | $7.60 | +294.74% | 1 | Nov 19, 2025 | |
| NGNE Neurogene | Maintains: Buy | $65 → $70 | $20.99 | +233.49% | 3 | Nov 13, 2025 | |
| KRRO Korro Bio | Downgrades: Neutral | n/a | $5.52 | - | 2 | Nov 13, 2025 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $5 → $10 | $4.22 | +136.97% | 1 | Nov 11, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $18 → $15 | $8.52 | +76.06% | 5 | Nov 10, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $100 → $110 | $82.70 | +33.01% | 6 | Nov 10, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Neutral | $60 → $55 | $55.52 | -0.94% | 2 | Oct 27, 2025 | |
| KYTX Kyverna Therapeutics | Maintains: Buy | $10 → $20 | $7.68 | +160.42% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $30.46 | +31.32% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $13 | $9.63 | +34.99% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $40 | $17.82 | +124.47% | 6 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $60 | $27.50 | +118.18% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $72.66 | +23.86% | 3 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $53.30 | +50.09% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $18.55 | +34.77% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $11.98 | +943.41% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.40 | +108.33% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $15.08 | +65.78% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $5 | $20.95 | -76.13% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $22.03 | +36.18% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.72 | +308.16% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $3.80 | -47.37% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $7.64 | +83.25% | 1 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.11 | +260.36% | 1 | Aug 11, 2025 |
MeiraGTx Holdings
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $8.20
Upside: +143.90%
Lyell Immunopharma
Nov 24, 2025
Maintains: Neutral
Price Target: $10 → $20
Current: $24.41
Upside: -18.07%
Cartesian Therapeutics
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $7.60
Upside: +294.74%
Neurogene
Nov 13, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $20.99
Upside: +233.49%
Korro Bio
Nov 13, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.52
Upside: -
CytomX Therapeutics
Nov 11, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $4.22
Upside: +136.97%
Intellia Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $8.52
Upside: +76.06%
Ionis Pharmaceuticals
Nov 10, 2025
Maintains: Buy
Price Target: $100 → $110
Current: $82.70
Upside: +33.01%
BioMarin Pharmaceutical
Oct 27, 2025
Maintains: Neutral
Price Target: $60 → $55
Current: $55.52
Upside: -0.94%
Kyverna Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $7.68
Upside: +160.42%
Oct 27, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $30.46
Upside: +31.32%
Oct 21, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.63
Upside: +34.99%
Oct 21, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $17.82
Upside: +124.47%
Oct 17, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $27.50
Upside: +118.18%
Oct 15, 2025
Reiterates: Buy
Price Target: $90
Current: $72.66
Upside: +23.86%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $53.30
Upside: +50.09%
Sep 17, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $18.55
Upside: +34.77%
Sep 11, 2025
Reiterates: Buy
Price Target: $125
Current: $11.98
Upside: +943.41%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.40
Upside: +108.33%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $15.08
Upside: +65.78%
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $20.95
Upside: -76.13%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $22.03
Upside: +36.18%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.72
Upside: +308.16%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.80
Upside: -47.37%
Aug 14, 2025
Reiterates: Buy
Price Target: $14
Current: $7.64
Upside: +83.25%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.11
Upside: +260.36%